Juha
Ranti

Doctoral Researcher, Internal Medicine

Contact

Areas of expertise

Expertese

Publications

Sort by:

Venetoclax combinations in untreated CLL: 5-year results and patient-reported outcome analysis of the CLL13/GAIA trial (2026)

Blood
Fürstenau, Moritz; Niemann, Carsten Utoft; Robrecht, Sandra; Rotbain, Emelie C.; Eurelings, Laura Elisabeth Maria; Giza, Adam; von Tresckow, Julia; Zhang, Can; Gregor, Michael; Thornton, Patrick; Staber, Philipp B.; Tadmor, Tamar; Lindstrom, Vesa; Juliusson, Gunnar; Janssens, Ann; da Cunha-Bang, Caspar; Schneider, Christof; Herishanu, Yair; O'Shea, Derville; Baumann, Michael; Widmer, Anouk Andrea; Nösslinger, Thomas; Bjørn Poulsen, Christian; Frederiksen, Henrik; Lotfi, Kourosh; Ranti, Juha; Enggaard, Lisbeth; Velders, Gerjo A.; Vekemans, Marie-Christiane Madeleine; de Heer, Koen; Snijders, Tjeerd J. F.; Siemes, Claire; Wendtner, Clemens-Martin; Knauf, Wolfgang U.; Kroeber, Alexander; Zahn, Mark-Oliver; Illmer, Thomas; Schöttker, Björn; Simon, Florian; Fink, Anna-Maria; Fischer, Kirsten; D'Brot, Ronald; Holmes, Emily Eva; Kreuzer, Karl-Anton; Ritgen, Matthias; Brüggemann, Monika; Tausch, Eugen; Stilgenbauer, Stephan; Levin, Mark-David; Hallek, Michael J.; Kater, Arnon P.; Eichhorst, Barbara F.
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

Fixed-Duration versus Continuous Treatment for Chronic Lymphocytic Leukemia (2025)

New England Journal of Medicine
Al-Sawaf, Othman; Stumpf, Janina; Zhang, Can; Simon, Florian; Bosch, Francesc; Feyzi, Emadoldin; Ghia, Paolo; Gregor, Michael; Kater, Arnon P.; Lindström, Vesa; Mattsson, Mattias; Niemann, Carsten U.; Staber, Philipp B.; Tadmor, Tamar; Thornton, Patrick; Wendtner, Clemens-Martin; Janssens, Ann; Noesslinger, Thomas; Bohn, Jan-Paul; da Cunha-Bang, Caspar; Poulsen, Christian B.; Ranti, Juha; Illmer, Thomas; Schoettker, Bjoern; Böttcher, Sebastian; Gaska, Tobias; Vandenberghe, Elisabeth; Clifford, Ruth; Benjamini, Ohad; Frustaci, Anna Maria; Scarfò, Lydia; Sportoletti, Paolo; Schreurs, John; Levin, Mark-David; van der Straaten, Hanneke; van der Klift, Marjolein; Tran, Hoa; de la Serna, Javier; Loscertales, Javier; Lindblad, Oscar; Bergendahl Sandstedt, Anna; Goede, Jeroen; Baumann, Michael; Fink, Anna Maria; Fischer, Kirsten; Ritgen, Matthias; Kreuzer, Karl-Anton; Schneider, Christof; Tausch, Eugen; Stilgenbauer, Stephan; Robrecht, Sandra; Eichhorst, Barbara; Hallek, Michael
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

Long term follow-up of MRD guided treatment of Ibrutinib plus Venetoclax for Relapsed CLL: phase 2 VISION/HO141 trial (2025)

Blood Advances
Niemann, Carsten Utoft; Dubois, Julie; Nasserinejad, Kazem; da Cunha-Bang, Caspar; Kersting, Sabina; Enggaard, Lisbeth; Veldhuis, Gerrit-Jan; Mous, Rogier; Mellink, Clemens H.M.; van der Kevie-Kersemaekers, Anne-Marie F.; Dobber, Johan A.; Bjørn Poulsen, Christian; Razawy, Wida; Hollestein, Rene; Frederiksen, Henrik; Janssens, Ann; Schjødt, Ida; Dompeling, Ellen C.; Ranti, Juha; Brieghel, Christian; Mattsson, Mattias; Bellido, Mar; Tran, Hoa T.T.; Kater, Arnon P.; Levin, Mark-David
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

Minimal residual disease-guided stop and start of venetoclax plus ibrutinib for patients with relapsed or refractory chronic lymphocytic leukaemia (HOVON141/VISION): primary analysis of an open-label, randomised, phase 2 trial (2022)

Lancet Oncology
Kater Arnon P., Levin Mark-David, Dubois Julie, Kersting Sabina, Enggaard Lisbeth, Veldhuis Gerrit J., Mous Rogier, Mellink Clemens H.M., van der Kevie-Kersemaekers Anne-Marie F., Dobber Johan A., Poulsen Christian B., Frederiksen Henrik, Janssens Ann, Schjødt Ida, Dompeling Ellen C., Ranti Juha, Brieghel Christian, Mattsson Mattias, Bellido Mar, Tran Hoa T.T., Nasserinejad Kazem, Niemann Carsten U.
(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))